Tuberous Scerlosis Complex clinical trials

Explore recruiting tuberous scerlosis complex clinical trials.

Also recruiting in Europe

Tuberous Scerlosis Complex trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3b/4, Interventional, Multicenter, Open-Label, Single-Arm Study to Assess Behavioral and Other Co-occurring Outcomes Following Treatment With EPID(I/Y)OLEX as Add-on Therapy in Participants (Aged 1 to 65 Years Old) With Seizures Associated With Tuberous Sclerosis Complex (EpiCom)

Poland

Phase III and phase IV (Integrated) EU CTIS Study details

Tuberous Scerlosis Complex trials by city

Tuberous Scerlosis Complex in Toronto Tuberous Scerlosis Complex in Vancouver Tuberous Scerlosis Complex in Montreal Tuberous Scerlosis Complex in Calgary Tuberous Scerlosis Complex in Edmonton Tuberous Scerlosis Complex in Ottawa Tuberous Scerlosis Complex in Winnipeg Tuberous Scerlosis Complex in Quebec City Tuberous Scerlosis Complex in Hamilton Tuberous Scerlosis Complex in Kitchener Tuberous Scerlosis Complex in London Tuberous Scerlosis Complex in Halifax Tuberous Scerlosis Complex in New York Tuberous Scerlosis Complex in Los Angeles Tuberous Scerlosis Complex in Chicago Tuberous Scerlosis Complex in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease